In non-small-cell lung cancer (NSCLC) and glioblastoma multiforme (GBM), for example, overexpression of CS-GRP78 is one of the responsibles for radio-resistance [214], while administration of anti-GRP78 delayed tumor growth and enhanced the efficacy of the radiation treatment. The gene discussed is HSPA5; the disease is glioblastoma.